Shimobi Onuoha

2.2k total citations
28 papers, 723 citations indexed

About

Shimobi Onuoha is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shimobi Onuoha has authored 28 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shimobi Onuoha's work include CAR-T cell therapy research (16 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Shimobi Onuoha is often cited by papers focused on CAR-T cell therapy research (16 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Shimobi Onuoha collaborates with scholars based in United Kingdom, Italy and Germany. Shimobi Onuoha's co-authors include Martin Pulé, Mathieu Ferrari, Brian Philip, Costantino Pitzalis, Paul Maciocia, Simon Thomas, Shaun Cordoba, Patrycja Wawrzyniecka, Teresa Marafioti and Anna L. Mallam and has published in prestigious journals such as Nature Medicine, Blood and Molecular Cell.

In The Last Decade

Shimobi Onuoha

27 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shimobi Onuoha United Kingdom 13 461 249 178 145 135 28 723
Nicole Berndt Germany 17 461 1.0× 275 1.1× 367 2.1× 89 0.6× 204 1.5× 34 798
Kathleen Gallagher United States 12 633 1.4× 196 0.8× 195 1.1× 151 1.0× 212 1.6× 32 837
Premal Lulla United States 17 702 1.5× 258 1.0× 290 1.6× 231 1.6× 128 0.9× 64 938
Pranay D. Khare United States 10 408 0.9× 193 0.8× 197 1.1× 188 1.3× 139 1.0× 17 701
Ling Yi United States 9 616 1.3× 331 1.3× 479 2.7× 76 0.5× 54 0.4× 16 922
Reona Sakemura United States 13 717 1.6× 249 1.0× 261 1.5× 227 1.6× 261 1.9× 54 879
Alyssa Sheih United States 9 440 1.0× 217 0.9× 233 1.3× 136 0.9× 103 0.8× 21 699
Vicky Torrano United States 6 791 1.7× 181 0.7× 389 2.2× 187 1.3× 106 0.8× 9 893
Yongxian Hu China 21 1.1k 2.4× 475 1.9× 353 2.0× 324 2.2× 261 1.9× 119 1.4k
Eric Chen United States 7 556 1.2× 176 0.7× 238 1.3× 216 1.5× 158 1.2× 12 826

Countries citing papers authored by Shimobi Onuoha

Since Specialization
Citations

This map shows the geographic impact of Shimobi Onuoha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shimobi Onuoha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shimobi Onuoha more than expected).

Fields of papers citing papers by Shimobi Onuoha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shimobi Onuoha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shimobi Onuoha. The network helps show where Shimobi Onuoha may publish in the future.

Co-authorship network of co-authors of Shimobi Onuoha

This figure shows the co-authorship network connecting the top 25 collaborators of Shimobi Onuoha. A scholar is included among the top collaborators of Shimobi Onuoha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shimobi Onuoha. Shimobi Onuoha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hotblack, Alastair, Reyisa Bughda, Anna Bulek, et al.. (2024). Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein–Protein Interaction. ACS Chemical Biology. 19(2). 308–324. 4 indexed citations
2.
Mekkaoui, Leila, Emma Bentley, Mathieu Ferrari, et al.. (2021). Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike. BIO-PROTOCOL. 11(16). e4194–e4194. 3 indexed citations
3.
Hotblack, Alastair, Evangelia Kokalaki, Gordon Weng-Kit Cheung, et al.. (2021). Tunable control of CAR T cell activity through tetracycline mediated disruption of protein–protein interaction. Scientific Reports. 11(1). 21902–21902. 18 indexed citations
4.
Nannini, Francesco, Patrycja Wawrzyniecka, Mathieu Ferrari, et al.. (2021). Anti-CD21 Chimeric Antigen Receptor (CAR)-T Cells for T Cell Acute Lymphoblastic Leukaemia (T-ALL). Blood. 138(Supplement 1). 902–902. 7 indexed citations
5.
Ferrari, Mathieu, Shimobi Onuoha, Liliane Fossati‐Jimack, et al.. (2021). Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis. Frontiers in Immunology. 12. 640070–640070. 13 indexed citations
6.
Ferrari, Mathieu, Emma Bentley, Giada Mattiuzzo, et al.. (2021). A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency. Antiviral Research. 194. 105147–105147. 11 indexed citations
7.
Nannini, Francesco, Patrycja Wawrzyniecka, Leila Mekkaoui, et al.. (2020). A primer set for the rapid isolation of scFv fragments against cell surface antigens from immunised rats. Scientific Reports. 10(1). 19168–19168. 4 indexed citations
8.
Peruta, Marco Della, Mathew Robson, Philip Fei Wu, et al.. (2020). Abstract 1070: AUTO7: Anti-PSMA humanized CAR T-cell with improved persistence and resistance to tumor microenvironment for metastatic castration resistant prostate cancer (mCRPC). Cancer Research. 80(16_Supplement). 1070–1070. 1 indexed citations
9.
Nannini, Francesco, Reyisa Bughda, James Sillibourne, et al.. (2020). Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments. mAbs. 13(1). 1864084–1864084. 16 indexed citations
10.
Maciocia, Paul, Shimobi Onuoha, Patrycja Wawrzyniecka, et al.. (2018). Analysis of T-Cell Receptor Beta-Constant Region Expression for Rapid Assessment of T-Cell Clonality. Blood. 132(Supplement 1). 2867–2867. 1 indexed citations
11.
Philip, Brian, Christopher G. Davis, Shimobi Onuoha, et al.. (2018). A Rapamycin-Activated Caspase 9-Based Suicide Gene. Molecular Therapy. 26(5). 1266–1276. 72 indexed citations
12.
Baldan, Vania, Evangelia Kokalaki, Shimobi Onuoha, et al.. (2017). A Dominant Negative SHP-2 Which Abrogates PD-1 Signalling Pathways and Restores Function of Cytotoxic CAR T Cells. Blood. 130. 3190–3190. 5 indexed citations
13.
Maciocia, Paul, Patrycja Wawrzyniecka, Brian Philip, et al.. (2017). Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies. Nature Medicine. 23(12). 1416–1423. 192 indexed citations
14.
Lee, Lydia, Benjamin Draper, Brian Philip, et al.. (2017). An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma. Blood. 131(7). 746–758. 134 indexed citations
15.
Kramer, Anne Marijn, Sara Ghorashian, Gordon Weng-Kit Cheung, et al.. (2016). Construction and Pre-Clinical Evaluation of a New Anti-CD19 Chimeric Antigen Receptor. Blood. 128(22). 1627–1627. 3 indexed citations
16.
Maciocia, Paul, Patrycja Wawrzyniecka, Brian Philip, et al.. (2016). Targeting T-Cell Receptor β-Constant Domain for Immunotherapy of T-Cell Malignancies. Blood. 128(22). 811–811.
17.
Ferrari, Mathieu, Shimobi Onuoha, & Costantino Pitzalis. (2015). Trojan horses and guided missiles: targeted therapies in the war on arthritis. Nature Reviews Rheumatology. 11(6). 328–337. 53 indexed citations
18.
Ferrari, Mathieu, Shimobi Onuoha, & Costantino Pitzalis. (2015). Going with the flow: harnessing the power of the vasculature for targeted therapy in rheumatoid arthritis. Drug Discovery Today. 21(1). 172–179. 13 indexed citations
19.
Onuoha, Shimobi, Mathieu Ferrari, Daniele Sblattero, & Costantino Pitzalis. (2015). Rational Design of Antirheumatic Prodrugs Specific for Sites of Inflammation. Arthritis & Rheumatology. 67(10). 2661–2672. 17 indexed citations
20.
Mallam, Anna L., Shimobi Onuoha, J. Günter Grossmann, & Sophie Jackson. (2008). Knotted Fusion Proteins Reveal Unexpected Possibilities in Protein Folding. Molecular Cell. 30(5). 642–648. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Berndt Breakdown of academic impact, for papers by Kathleen Gallagher Breakdown of academic impact, for papers by Premal Lulla Breakdown of academic impact, for papers by Pranay D. Khare Breakdown of academic impact, for papers by Ling Yi Breakdown of academic impact, for papers by Reona Sakemura Breakdown of academic impact, for papers by Alyssa Sheih Breakdown of academic impact, for papers by Vicky Torrano Breakdown of academic impact, for papers by Yongxian Hu Breakdown of academic impact, for papers by Eric Chen
Rankless by CCL
2026